RCE recce pharmaceuticals ltd

Ann: Recce Applies for Dual Listing on Frankfurt Stock Exchange, page-39

  1. 276 Posts.
    lightbulb Created with Sketch. 297


    Like everything else there are pros & cons when it comes to dual listing. The main advantage, increased liquidity, greater access to capital, increased chance of takeover and higher public profile.
    The main disadvantages I see is initial and ongoing costs, and higher workload on management.


    Personally I don’t really care much for dual listing, but this could be very different and possibly a very smart and well timed move by management with some announcements of Substance around the corner!!


    Time will tell, but I honestly believe that this has been a well thought out plan by management to capture the largest audience possible and to reap the best outcome for all shareholders!wink.png
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
44.5¢
Change
0.080(21.9%)
Mkt cap ! $128.6M
Open High Low Value Volume
37.5¢ 44.5¢ 37.5¢ $191.2K 477.3K

Buyers (Bids)

No. Vol. Price($)
2 12222 44.0¢
 

Sellers (Offers)

Price($) Vol. No.
45.0¢ 10976 2
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.